R+D 100 Award for Boston Micromachines’ Optical Coherence Tomography Instrument

Boston Micromachines has bagged the 2010 the R&D 100 Award for its Adaptive Optics Optical Coherence Tomography (AO-OCT) instrument based on microelectromechanical systems (MEMS). The company collaborated with Indiana University School of Optometry, University of California and the Lawrence Livermore National Laboratory to develop the AO-OCT clinical apparatus instrument.

The AO-OCT instrument delivers three-dimensional retinal images of high resolution for optometrists in a non-invasive manner. The optometrists can view the cellular-level structure of the human retina using this instrument. It is a major advancement over the existing retinal cameras and optical coherence tomography.

The instrument enables doctors to diagnose retinal defects at an earlier stage and monitor the development of the disease as well. The instrument also tracks the advancement of genetic therapy, which helps in reversing the retinal diseases.

The AO-OCT instrument follows the same principles of adaptive optics that help astronomers view galaxies and stars using the Keck Telescope, which is ground based, at a higher resolution compared to that of the Hubble Space Telescope.

R&D magazine’s editors and an independent panel of judges have decided the winners of the award, which honors the top 100 advanced products that have been launched last year. The magazine’s editorial director, Rita Peters, said that the R&D 100 Awards recognizes the most advanced products that reach the marketplace.

Source: http://www.bostonmicromachines.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.